BOLD vs LYB · P/E 0.1, $24.6M cap vs P/E 21, rev $40.30B
Boundless Bio, Inc. Common Stock (BOLD) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the BOLD and LYB stock pages for the full models.
Not investment advice.